LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2Jeffrey D. Bradley, Mustafa Özgüroğlu, Zofia F. Bielecka et al.|ESMO Open|2024Cited by 74
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Aaron Cumpston, Mehdi Hamadani et al.|Supportive Care in Cancer|2016Cited by 8
Impact of body mass index (BMI) on plerixafor efficacy during hematopoietic progenitor cell (HPC) mobilization.Rebecca Gonzalez, Aaron Cumpston, Alexandra Shillingburg et al.|Journal of Clinical Oncology|2014Cited by 0